Unique Ingredient Identifier 1K09F3G675 is listed as a ingredient substance
| RN | 1309-37-1 |
| EC | 215-168-2 |
| NCIT | C75672 |
| RXCUI | 1310572 |
| PUBCHEM | 14833 |
| MF | 2Fe.3O |
| INCHI KEY | LIKBJVNGSGBSGK-UHFFFAOYSA-N |
| SMILES | [O--].[O--].[O--].[Fe+3].[Fe+3] |
UNII 1K09F3G675 FERRIC OXIDE RED is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | FILM, SOLUBLE | 0.03 MG |
| BUCCAL | TABLET | 0.4 MG |
| ORAL | CAPSULE | 2.64 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE) | NA |
| ORAL | CAPSULE, COATED | 0.1152 MG |
| ORAL | CAPSULE, DELAYED ACTION | 0.55 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 2.3 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 2 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 0.5998 mg |
| ORAL | CAPSULE, HARD GELATIN | 0.3 MG |
| ORAL | CAPSULE, SOFT GELATIN | 2.28 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | NA |
| ORAL | DROPS | NA |
| ORAL | POWDER, FOR ORAL SUSPENSION | 0.75 MG/5ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 2.7 MG/1PKT |
| ORAL | TABLET | 13 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 1 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 1.5 MG |
| ORAL | TABLET, CHEWABLE | 0.5 MG |
| ORAL | TABLET, COATED | NA |
| ORAL | TABLET, CONTROLLED RELEASE | 5.24 MG |
| ORAL | TABLET, DELAYED ACTION | 3 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 2.3 MG |
| ORAL | TABLET, DELAYED RELEASE | 1.1 MG |
| ORAL | TABLET, EXTENDED RELEASE | 4.08 MG |
| ORAL | TABLET, FILM COATED | 3 MG |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 0.1 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 0.11 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 0.64 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 0.15 MG |
| ORAL | TABLET, SUSTAINED ACTION | 3 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 3.6 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 1.8 MG |
| SUBLINGUAL | TABLET | 1 MG |
| TOPICAL | LOTION | NA |